A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/21 (2006.01)
Patent
CA 2322785
A method is described for using interferon in the treatment of human patients afflicted with fibromyalgia to alleviate one or more symptoms associated with that disease state. Fibromyalgia positive patients treated bucally, sublingually or by oral ingestion administration of low doses of interferon enjoy a reduction in clinical symptoms of the disease.
Cette invention a trait à une méthode d'utilisation de l'interféron dans le traitement de patients humains atteints de fibromyalgie, ce traitement ayant pour but d'atténuer un ou plusieurs symptômes liés à cet état pathologique. Les patients formellement atteints de fibromyalgie traités par l'administration, par voie buccale, sublinguale ou par ingestion orale, de faibles doses d'interféron, bénéficient d'une atténuation des symptômes cliniques de la maladie.
Richards Alan B.
Sherwood Edward
Amarillo Biosciences Inc.
Smart & Biggar
LandOfFree
Treatment of fibromyalgia with low interferon doses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of fibromyalgia with low interferon doses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of fibromyalgia with low interferon doses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1724292